Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Desenlaces perinatales, en un centro de tercer nivel de México de pacientes con colestasis intrahepática del embarazo

Perinatal outcomes of patients with intrahepatic cholestasis of pregnancy in a third level center in Mexico.

Ginecol Obstet Mex. 2021; 89 (10): 760-769.

https://doi.org/10.24245/gom.v89i10.5664

Francisco Ibargüengoitia-Ochoa,1 Carmen Selene García-Romero,2 Cintia María Sepúlveda-Rivera,3 Josefina Lira-Plascencia,4 Fabiola Gallardo-Gómez 5

1 Médico adscrito al Departamento de Obstetricia.
2 Médico adscrita al laboratorio de Biología Molecular y Virología.
3 Residente quinto año Ginecología Oncológica.
4 Coordinadora del Departamento de Medicina de la Adolescente.
5 Residente cuarto año Ginecología y Obstetricia.
Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Ciudad de México.


Corrrespondencia:

Fabiola Gallardo Gómez
fabiolagallardo3191@gmail.com

Debe citarse como:

Ibargüengoitia-Ochoa F, García-Romero CS, Sepúlveda-Rivera CM, Lira-Plascencia J, Gallardo-Gómez F. Desenlaces perinatales, en un centro de tercer nivel de México, de pacientes con colestasis intrahepática del embarazo. Ginecol Obstet Mex. 2021; 89 (10): 760-769. https://doi.org/10.24245/gom.v89i10.5664

Resumen

OBJETIVO: Describir la atención, tratamiento, desenlaces perinatales y complicaciones asociadas con la colestasis intrahepática del embarazo.

MATERIALES Y MÉTODOS: Estudio de serie de casos, retrospectivo y observacional de pacientes embarazadas, con diagnóstico de colestasis intrahepática atendidas en el Instituto Nacional de Perinatología entre los meses de enero de 2016 a diciembre de 2020. Se evaluaron las características obstétricas, los datos demográficos, clínicos, bioquímicos y de tratamiento, la finalización del embarazo y los desenlaces perinatales.

RESULTADOS: Se analizaron 67 casos de colestasis intrahepática que arrojaron una incidencia de 0.57%. La edad promedio de las pacientes fue 29.0 ± 6.8 años, 30 de 67 eran primigestas, 12 tuvieron el antecedente de colestasis intrahepática en el embarazo previo y 7 de óbito. El inicio de la enfermedad fue en el tercer trimestre en 41 de 67 pacientes. En los estudios de bioquímica 32 de 67 tuvieron valores de ácidos biliares entre 10 y 39 µM/L; 12 de las 67: 40-99 µM/L y 23 más de 100 (µM/L). Se administró tratamiento con ácido ursodesoxicólico a 63 de 67 y ante la falta de respuesta se agregó rifampicina. El promedio de semanas de gestación fue 35.6 ± 2.0 semanas con peso promedio de 2397 ± 572 g. Se encontró líquido amniótico con meconio en 10 neonatos y restricción del crecimiento en 20 de 67; se registraron 2 óbitos.

CONCLUSIONES: Este es el primer estudio efectuado en México que describe la incidencia de la enfermedad y se utiliza la determinación de los ácidos biliares para establecer el diagnóstico. Los desenlaces perinatales coinciden con lo reportado en la bibliografía.

PALABRAS CLAVE: Colestasis intrahepática; embarazo; perinatal; tercer trimestre; ácido ursodesoxicólico; rifampicina; líquido amniótico; meconio.

Abstract

OBJECTIVE: To describe the care, treatment, perinatal outcomes and complications associated with intrahepatic cholestasis of pregnancy.

MATERIALS AND METHODS: A retrospective and observational case series study of pregnant patients with a diagnosis of intrahepatic cholestasis seen at the National Institute of Perinatology between January 2016 and December 2020. Obstetric characteristics, demographic, clinical, biochemical and treatment data, pregnancy termination and perinatal outcomes were evaluated.

RESULTS: Sixty-seven cases of intrahepatic cholestasis were analyzed, yielding an incidence of 0.57%. The mean age of the patients was 29.0 ± 6.8 years, 30 of 67 were primigravidases, 12 had a history of intrahepatic cholestasis in the previous pregnancy and 7 had an abortion. The onset of the disease was in the third trimester in 41 of 67 patients. In biochemistry studies 32 of 67 had bile acid values between 10 and 39 µM/L; 12 of 67: 40-99 µM/L and 23 more than 100 (µM/L). Treatment with ursodeoxycholic acid was administered to 63 of 67 and rifampicin to 4 patients. The mean number of weeks of gestation was 35.6 ± 2.0 weeks with a mean weight of 2397 ± 572 g. Amniotic fluid with meconium was found in 10 neonates and growth restriction in 20 of 67; there were 2 recorded abortions.

CONCLUSIONS: This is the first study carried out in Mexico in which the incidence of the disease is described, and the determination of bile acids is used to establish the diagnosis. Perinatal outcomes coincide with those reported in the literature.

KEYWORDS: Intrahepatic cholestasis; Pregnancy; Perinatal; Third trimester; Ursodeoxycholic acid; Rifampicin; Amniotic fluid; Meconium.

    1. Guarino M, Cossiga V, Morisco F. The interpretation of liver function tests in pregnancy. Best Pract Res Clin Gastroenterol 2020; 44-45: 101667. https://doi.org/10.1016/j.bpg.2020.101667
    2. Mikolasevic I, Filipec K T, Jakopcic I, et al. Liver disease during pregnancy: a challenging clinical issue. Med Sci Monit 2018; 24: 4080-90. doi: 10.12659/MSM.907723
    3. Diken Z, Usta I M, Nassar A H. A clinical approach to intrahepatic cholestasis of pregnancy. Am J Perinatol 2014; 31: 1-8. doi:10.1055/s-0033-1333673
    4. Piechota J, Jelski W. Intrahepatic cholestasis of pregnancy: a review of the literature. J Clin Med 2020; 9: 1361-7. doi: https://doi.org/10.3390/jcm9051361
    5. Brouwers L, Koster MP, Page CGC, et al. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol 2015; 212: 100.e1-100.e7. doi:10.1016/j.ajog.2014.07.026
    6. Marschall H U. Management of intrahepatic cholestasis of pregnancy. Expert Rev Gastroenterol Hepatol 2015; 9: 1273-9. doi:10.1586/17474124.2015.1083857
    7. Ozkan S, Ceylan Y, Ozkan O V et al. Review of a challenging clinical issue: intrahepatic cholestasis of pregnancy. World J Gastroenterol 2015; 21: 7134-41. doi: 10.3748/wjg.V21.i23.7134
    8. Kawakita T, Parikh L I, Ramsey P S et al. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol 2015; 213: 570.e1-8. doi: org/10.1016/j.ajog.2015.06.021
    9. Reyes H, González M C, Ribalta J et al. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Inter Med 1978; 88: 487-93. doi:10.7326/0003-4819-88-4-487
    10. Deepak J, James A, Quaglia A et al. Liver disease in pregnancy. Lancet 2010; 375: 594-605. doi:10.1016/S0140-6736(09)61495-1
    11. González B R, Mortara G A S, Martínez U A y col. Colestasis intra-hepática del embarazo: reporte de un caso y revisión de la bibliografía. Ginec Obstet Méx 2013; 81: 652-7. https://ginecologiayobstetricia.org.mx/articulo/colestasis-intrahepatica-del-embarazo-reporte-de-un-caso-y-revision-de-la-bibliografia
    12. Gallardo G J M, Lemionet E D, Acevedo G S y col. Resultados perinatales adversos en colestasis intra-hepática del embarazo. Perinatol Reprod Hum 2018; 32: 131-7. DOI: https://www.sciencedirect.com/science/article/pii/S0187533718301055
    13. Marschall H U, Wilkstorm S E, Ludvigsson J F et al. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study. Hepatology 2013; 58: 1385-91. doi: https://doi.org/10.1002/hep.26444
    14. Geenes V, Chappell L C, Seed P T et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatogy 2014; 59: 1482-91. doi:10.1002/hep.26617
    15. Ibrahim S H, Jonas M M, Taylor S A et al. Liver diseases in the perinatal period: interactions between mother and infant. Hepatology 2020; 71: 1474-85. doi:10.1002/hep.31109
    16. Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol 2014; 124: 120-33. doi: 10.1097/AOG.0000000000000346
    17. Heikkinen J. Serum bile acids in the early diagnosis of intrahepatic cholestasis of pregnancy. Obstet Gynecol 1983; 61: 581-7. Serum Bile Acids in the Early Diagnosis of Intrahepatic Cholesterol. Obstetrics & Gynecology (lww.com)
    18. Prati D, Taioli E, Zanella A et al. Updated definitions of heatlhy ranges of serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1-10. doi:10.7326/0003-4819-137-1-200207020-00006
    19. Katarey D, Westbrook R H. Pregnancy-specific liver diseases. Best Pract Res Clin Obstet Gynaecol 2020; 68: 12-22. doi: 10.1016/j.bpobgyn.2020.03.013
    20. Biccoca M J, Sperling J D, Cauhan S P. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol 2018; 231: 180-7 doi: org/10.1016/j.ejogrb.2018.10.041
    21. Jin J, Pan S L, Huang L P et al. Risk factors for adverse fetal outcomes among women with early versus late-onset intrahepatic cholestasis of pregnancy. Int J Gynaecol Obstet 2015; 128: 236-40. doi:10.1016/j.ijgo.2014.09.013
    22. Ovadia C, Seed P, Sklavaunes A et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analysis. Lancet 2019; 393: 899-909. doi:org/10.1016/S0140-6736(18)31877-4
    23. Patel S, Pinheiro M, Felix J C. A case-control review of placentas from patients with intrahepatic cholestasis of pregnancy. Fetal Pediatr Pathol 2014; 33: 210-5.doi: 10.3109/15513815.2014.899413
    24. Herrera C A, Manuck T A, Stoddard G J et al. Perinatal outcomes associated with intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med 2018; 31: 1913-20. DOI: https://doi.org/10.1080/14767058.2017.1332036.
    25. Ekiz A, Kaya B, Eftal A M et al. Alanine aminotransferase as a predictor of adverse perinatal outcome in women with intrahepatic cholestasis of pregnancy. Pak J Med Sci 2016; 32: 418-22. doi: org/10.12669/pjms.322.9057
    26. Li L, Chen Y H, Yang Y Y et al. Effect of intrahepatic cholestasis of pregnancy on neonatal birth weight: a meta-analysis. J Clin Res Pediatr Endocrinol 2018; 10: 38-43 doi: 10.4274/jcrpe.4930
    27. Palma J, Reyes H, Ribalta J et al. Effects of ursodesoxicolic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992; 15: 1043-7. doi:10.1002/hep.1840150612
    28. Bacq Y, Sentilhes L, Reyes H B et al. Efficacy of ursodesoxicolic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology 2012: 143: 1492-501. doi:10.1053/j.gastro.2012.08.004
    29. Walker K F, Chappell L C, Hague W M et al. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. Cochrane Database Syst Rev 2020; 7: CD 000493 doi: 10.1002/14651858.CD000493.pub3
    30. Geenes V, Chambers J, Khuruma R et al. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol 2015; 189: 59-63. doi: 10.1016/j.ejogrb.2015.03.020
    31. Wilkstrom S E, Marschall H U, Ludvigsson J F et al. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG 2013; 120: 717-23. doi:10.1111/1471-0528.12174.
    32. Arafa A, Dong J Y. Association between intrahepatic cholestasis of pregnancy and risk of gestational diabetes and preeclampsia: a systematic review and meta-analysis. Hypertens Pregnancy 2020; 39: 354-60. doi: 10.1080/10641955.2020.1758939
    33. Palmer K R, Xiaohua L, Mol B W. Management of intrahepatic cholestasis of pregnancy. Lancet 2019; 393: 853-4. doi: 10.1016/S0140-6736(18)32323-7
    34. Medically indicated late-preterm and early-term deliveries. ACOG Committee Opinion No. 764. American Collegue Obstetrics and Gynecology. Obstet Gynecol 2019; 133: e151-5. doi: 10.1097/AOG.0000000000003083
    35. Lee H L, Greenberg M, Metz ID, et al. Society of Maternal-Fetal Medicine Series # 53. Intrahepatic Cholestasis of Pregnancy. Am J Obstet Gynecol 2021; 224: B2-B9. doi: 10.1016/j.ajog.2020.11.002
    36. Wilkstrom S E A, Stephansson O, Thruresson M, et al. Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: a population-based cohort intrahepatic cholestasis study. J Hepatol 2015; 63: 456-61. doi: https://doi.org/10.1016/j.jhep.2015.03.010
    37. Floreani A, Garvasi M T. New insights on intrahepatic cholestasis of pregnancy. Clin Liv Dis 2016; 20: 177-89. doi: org/10.1016/j.cld.2015.08.010.
    38. Carballo-Núñez E y col. Resultados perinatales en pacientes con colestasis del embarazo. Ginecol Obstet Mex 2015; 83 (12): 776-84. https;//www.medigraphic.com/pdfs/ginobsmex/gom-2015/gom1512f.pdf

Comentarios